Population screening for autoimmune thyroid disease.
Whether or not healthy adults in the community would benefit from screening for autoimmune thyroid disease is controversial. Although the prevalence of unsuspected overt thyroid disease is low, a significant proportion of subjects tested will have evidence of mild thyroid failure or excess. This article assesses whether subclinical thyroid disease is of sufficient clinical importance to warrant screening and, once detected and confirmed, to justify therapy. Population screening for autoimmune thyroid disease is assessed against recently revised screening criteria, using data from epidemiologic studies. Recommendations are proposed that may be applied in any iodine-replete community.
Tunbridge
W M
WM
Oxford University, United Kingdom.
Vanderpump
M P
MP
D000293:Adolescent; D000328:Adult; D000368:Aged; D001327:Autoimmune Diseases / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D002648:Child; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000175:diagnosis / Q000453:epidemiology; D007037:Hypothyroidism / Q000175:diagnosis / Q000453:epidemiology; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D012307:Risk Factors; D013959:Thyroid Diseases / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control / Q000628:therapy